# METiS TechBio（7666.HK）是一家專注於AI驅動奈米傳遞創新的科技生物公司。

*biotech · news · 2026-05-14 · The Manila Times*

## Key points

- METiS TechBio是全球首家在港交所公開上市的AI驅動藥物傳遞公司。
- 其專有的NanoForge平台包含全球唯一的全新脂質生成演算法及語言模型。
- MTS-004是中國首個完成三期臨床試驗的AI輔助製劑藥物。
- MTS-105有望成為全球首個體內mRNA編碼的TCE實體腫瘤療法。

**Companies:** BlackRock, UBS Asset Management, Deutsche Bank Securities, Jefferies, CITIC Securities, METiS TechBio
**Countries:** China, Hong Kong, South Korea, Japan, United States

[Read the full story on The Manila Times](https://www.manilatimes.net/2026/05/14/tmt-newswire/pr-newswire/metis-techbio-the-worlds-first-publicly-listed-ai-powered-drug-delivery-company-debuts-on-the-hong-kong-stock-exchange-the-spacex-of-pharmaceuticals-ushers-in-a-new-era-of-biopharmaceuticals/2343541)

---

Canonical: https://newsio.io/zh-TW/n/de80b7c2-31dc-4172-b6a9-a44ae16f814a/metis-techbio7666-hkai
Summarized by Newsio from The Manila Times. https://newsio.io/how-it-works